Shao ZM - Search Results

1

Dissecting the heterogeneity of the alternative polyadenylation profiles in triple-negative breast cancers.

Wang L, Lang GT, Xue MZ, Yang L, Chen L, Yao L, Li XG, Wang P, Hu X, Shao ZM. Wang L, et al. Among authors: shao zm. Theranostics. 2020 Aug 21;10(23):10531-10547. doi: 10.7150/thno.40944. eCollection 2020. Theranostics. 2020. PMID: 32929364 Free PMC article.

2

Breast conservative therapy in east part of China: a retrospective cohort study.

Fan J, Wang L, Wang XJ, Wu J, Lu JS, Di GH, Shen KW, Han QX, Liu BL, Shen ZZ, Shao ZM. Fan J, et al. Among authors: shao zm. J Cancer Res Clin Oncol. 2006 Sep;132(9):573-8. doi: 10.1007/s00432-006-0104-x. Epub 2006 Jun 2. J Cancer Res Clin Oncol. 2006. PMID: 16741727

3

Cyclin e expression and prognosis in breast cancer patients: a meta-analysis of published studies.

Wang L, Shao ZM. Wang L, et al. Among authors: shao zm. Cancer Invest. 2006 Oct;24(6):581-7. doi: 10.1080/07357900600894799. Cancer Invest. 2006. PMID: 16982462

4

The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified.

Li WF, Hu Z, Rao NY, Song CG, Zhang B, Cao MZ, Su FX, Wang YS, He PQ, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Liu XY, Zhou J, Wang L, Zhao L, Liu YB, Yuan WT, Yang L, Shen ZZ, Huang W, Shao ZM. Li WF, et al. Among authors: shao zm. Breast Cancer Res Treat. 2008 Jul;110(1):99-109. doi: 10.1007/s10549-007-9708-3. Epub 2007 Sep 13. Breast Cancer Res Treat. 2008. PMID: 17851763

5

Frequent epigenetic inactivation of the receptor tyrosine kinase EphA5 by promoter methylation in human breast cancer.

Fu DY, Wang ZM, Wang BL, Chen L, Yang WT, Shen ZZ, Huang W, Shao ZM. Fu DY, et al. Among authors: shao zm. Hum Pathol. 2010 Jan;41(1):48-58. doi: 10.1016/j.humpath.2009.06.007. Epub 2009 Sep 5. Hum Pathol. 2010. PMID: 19733895

6

UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.

Jin W, Chen L, Chen Y, Xu SG, Di GH, Yin WJ, Wu J, Shao ZM. Jin W, et al. Among authors: shao zm. Breast Cancer Res Treat. 2010 Sep;123(2):359-73. doi: 10.1007/s10549-009-0652-2. Epub 2009 Nov 27. Breast Cancer Res Treat. 2010. PMID: 19943104

7

Involvement of MyoD and c-myb in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene.

Jin W, Liu Y, Chen L, Zhu H, Di GH, Ling H, Wu J, Shao ZM. Jin W, et al. Among authors: shao zm. Breast Cancer Res Treat. 2011 Feb;125(3):699-713. doi: 10.1007/s10549-010-0876-1. Epub 2010 Apr 3. Breast Cancer Res Treat. 2011. PMID: 20364308

8

ERβ and PEA3 co-activate IL-8 expression and promote the invasion of breast cancer cells.

Chen Y, Chen L, Li JY, Mukaida N, Wang Q, Yang C, Yin WJ, Zeng XH, Jin W, Shao ZM. Chen Y, et al. Among authors: shao zm. Cancer Biol Ther. 2011 Mar 1;11(5):497-511. doi: 10.4161/cbt.11.5.14667. Epub 2011 Mar 1. Cancer Biol Ther. 2011. PMID: 21266854 Free article.

9

Expression of dickkopf-1 and beta-catenin related to the prognosis of breast cancer patients with triple negative phenotype.

Xu WH, Liu ZB, Yang C, Qin W, Shao ZM. Xu WH, et al. Among authors: shao zm. PLoS One. 2012;7(5):e37624. doi: 10.1371/journal.pone.0037624. Epub 2012 May 23. PLoS One. 2012. PMID: 22649545 Free PMC article.

10

Expression of CXCL14 and its anticancer role in breast cancer.

Gu XL, Ou ZL, Lin FJ, Yang XL, Luo JM, Shen ZZ, Shao ZM. Gu XL, et al. Among authors: shao zm. Breast Cancer Res Treat. 2012 Oct;135(3):725-35. doi: 10.1007/s10549-012-2206-2. Epub 2012 Aug 22. Breast Cancer Res Treat. 2012. PMID: 22910931

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

639 results

Search Page

Filters